Tobias S, Shapiro A, Grant C, Patel P, Lysyshyn M, Ti L Drug checking identifies counterfeit alprazolam tablets Drug Alcohol Depend, 2021. PubMed


Betsos A, Valleriani J, Boyd J, Bardwell G, Kerr T, McNeil R "I couldn't live with killing one of my friends or anybody": A rapid ethnographic study of drug sellers' use of drug checking Int J Drug Policy, 2021. PubMed


Mohd Salleh NA, Voon P, Karamouzian M, Milloy MJ, Richardson L Methadone maintenance therapy service components linked to improvements in HIV care cascade outcomes: a systematic review of trials and observational studies Drug Alcohol Depend, 2021. PubMed


Moallef S, Homayra F, Milloy MJ, Bird L, Nosyk B, Hayashi K High prevalence of unmet healthcare need among people who use illicit drugs in a Canadian setting with publicly-funded interdisciplinary primary care clinics Subst Abus, 2021. PubMed


Morgan J, Schwartz C, Ferlatte O, Mnzisak C, Lachowsky N, Jollimore J, Hull M, Knight R Community-based participatory approaches to knowledge translation: HIV prevention case study of the Investigaytors program Arch Sex Behav, 2021. PubMed


Socías ME, Dong H, Wood E, Nolan S, Hayashi K, Kerr T, Milloy MJ Trajectories of retention in opioid agonist therapy and overdose risk during a community-wide overdose epidemic in a Canadian setting Am J Prev Med, 2021. PubMed


Dong H, Hayashi K, Fairbairn N, Milloy MJ, DeBeck K, Wood E, Kerr T Long term pre-treatment opioid use trajectories in relation to opioid agonist therapy outcomes among people who use drugs in a Canadian setting Addict Behav, 2021. PubMed


Socías ME, Nolan S Can extended-release injectable medications help curb United States and Canada's opioid overdose epidemic? J Addict Med, 2021. PubMed


Bach P, Ti L Hepatitis C and stimulant use disorder: challenges and opportunities Clin Infect Dis, 2020. PubMed


Long V, Arredondo J, Ti L, Grant C, DeBeck K, Milloy MJ, Lysyshyn M, Wood E, Kerr T, Hayashi K Factors associated with drug checking service utilization among people who use drugs in a Canadian setting Harm Reduct J, 2020. PubMed


BC Centre on Substance Use
4th Floor, 1190 Hornby Street,
Vancouver BC, V6Z 2K5

E: [email protected] | T: (778) 945-7616

24/7 Addiction Clinician Support Line: (778) 945-7619

ACTOC and POATSP: [email protected]




Copyright © 2026, BC Centre on Substance Use